Figure 3. Distribution of incremental costs versus incremental effects for cardiac resynchronization therapy versus medical therapy. For the base-case point estimate (white X), incremental costs = $30 252 and incremental effect = 0.282 quality-adjusted life-year (QALY).

Return to article